tert-Butyl 4-(((2,4-dichloropyrimidin-5-yl)methyl)amino)piperidine-1-carboxylate

Catalog No. :
ACRQZZ608
CAS No. :
1420844-37-6
Molecular Formula :
C15H22Cl2N4O2
Molecular Weight :
361.27

IUPAC Name:tert-butyl 4-(((2,4-dichloropyrimidin-5-yl)methyl)amino)piperidine-1-carboxylate

tert-Butyl 4-(((2,4-dichloropyrimidin-5-yl)methyl)amino)piperidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$346.00Login to see priceInquiryInquiry
250mg97%$485.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(((2,4-dichloropyrimidin-5-yl)methyl)amino)piperidine-1-carboxylate
IUPAC Nametert-butyl 4-(((2,4-dichloropyrimidin-5-yl)methyl)amino)piperidine-1-carboxylate
MDL No.MFCD24371911
Molecular FormulaC15H22Cl2N4O2
Molecular Weight361.27
SMILESClC1=NC(Cl)=NC=C1CNC(CC2)CCN2C(OC(C)(C)C)=O
InChI KeyWGBCNJZPVNZXLL-UHFFFAOYSA-N
Synonym4-[(2,4-Dichloro-pyrimidin-5-ylmethyl)-amino]-piperidine-1-carboxylic acid tert-butyl ester;TERT-BUTYL4-(((2,4-DICHLOROPYRIMIDIN-5-YL)METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE;1-Piperidinecarboxylic acid, 4-[[(2,4-dichloro-5-pyrimidinyl)methyl]amino]-, 1,1-dimethylethyl ester
CAS No.1420844-37-6

Synthetic Route by SureRoute

1. ACRQZZ608 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLEYR154 route compound structure diagram
    --
  2. Plus
  3. ACOUCV496 route compound structure diagram
    ACOUCV496871254-61-4 In Stock
  4. Then
  5. ACRQZZ608 route product structure diagram
    ACRQZZ6081420844-37-6
Inquiry

2. ACRQZZ608 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLEYR154 route compound structure diagram
    --
  2. Plus
  3. ACLTNV947 route compound structure diagram
    ACLTNV9477627-38-5 In Stock
  4. Then
  5. ACRQZZ608 route product structure diagram
    ACRQZZ6081420844-37-6
Inquiry

Comments (0)